Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective

HIGHLIGHTS

• who: Sarah P. Blagden from the consequences for clinical research in the UKUniversity of have published the research work: Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective, in the Journal: (JOURNAL) of 29/09/2022
• what: Despite the horror and tragedy of the COVID-19 pandemic, the clinical research community has gained important insights into how CID studies can be run rapidly and at scale.
• future: Protocol Development Seek to include all possible future modifications (e_g additional study arms) to reduce need for any substantial amendments . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.